寄生虫活力:评估人体抗疟药活性的更优指标
该研究在10例恶性疟原虫感染志愿者中单次给予青蒿琥酯(2 mg/kg),用qPCR测循环寄生虫浓度并以离体生长数学模型估算寄生虫活力。结果显示青蒿素敏感感染中活力寄生虫8小时内降至基线0.1%以下,而qPCR总量不变;耐药感染同期仅降至51.4%(SEM 4.6%)。提示青蒿琥酯体内药效快于清除半衰期所反映的程度。
要点
- 青蒿素敏感感染中,活力寄生虫8小时内降至基线<0.1%,快于qPCR总量变化。
- 耐药感染中活力寄生虫8小时仅降至基线51.4%(SEM 4.6%)。
- 寄生虫清除半衰期可能低估青蒿琥酯的体内药物活性。
核心结论
- 在青蒿素敏感感染中,青蒿琥酯体内药效快于寄生虫清除半衰期所指示的程度,活力检测可能优于清除率评估药物活性。
研究设计与样本
- 疟疾志愿者感染研究,纳入10例恶性疟原虫感染者,单次给予青蒿琥酯2 mg/kg。
- 以qPCR测循环寄生虫浓度,并以离体生长数学建模估算给药后寄生虫活力。
主要发现
- 青蒿素敏感感染中,活力寄生虫在给药后8小时内降至基线<0.1%,而qPCR测得循环寄生虫总数不变。
- 青蒿素耐药感染中,同一时段活力寄生虫降至基线51.4%(SEM 4.6%)。
临床怎么用
- 评估青蒿琥酯等抗疟药活性及监测耐药时,可考虑以寄生虫活力而非单纯清除半衰期作为补充指标。
局限性
- 样本量仅10例,结果来自志愿者感染研究,外推至自然感染人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Artemisinin derivatives are the leading class of antimalarial drugs due to their rapid onset of action and rapid clearance of circulating parasites. The parasite clearance half-life measures the rate of loss of parasites from blood after treatment, and this is currently used to assess antimalarial activity of novel agents and to monitor resistance. However, a number of recent studies have challenged the use of parasite clearance to measure drug activity, arguing that many circulating parasites may be nonviable. METHODS: Plasmodium falciparum-infected subjects (n = 10) in a malaria volunteer infection study were administered a single dose of artesunate (2 mg/kg). Circulating parasite concentration was assessed by means of quantitative polymerase chain reaction (qPCR). Parasite viability after artesunate administration was estimated by mathematical modeling of the ex vivo growth of parasites collected from subjects. RESULTS: We showed that in artemisinin-sensitive infection, viable parasites declined to <0.1% of baseline within 8 hours after artesunate administration, while the total number of circulating parasites measured with quantitative polymerase chain reaction remained unchanged. In artemisinin-resistant infections over the same interval, viable parasites declined to 51.4% (standard error of the mean, 4.6%) of baseline. CONCLUSIONS: These results demonstrate that in vivo drug activity of artesunate is faster than is indicated by the parasite clearance half-life.
引用
- Rebelo M, Pawliw R, Gower J, et al. Parasite Viability as a Superior Measure of Antimalarial Drug Activity in Humans. J Infect Dis. 2021. PMID: 33119072. doi:10.1093/infdis/jiaa678
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。